Bina develops next-generation genomic management solutions by utilizing industry best practices in big data and information management. This expertise helps you organize, find and share insights as data volumes increase, genomic pipelines evolve and collaborations become global.
Bina’s cost-effective and reliable technology accelerates secondary analysis for custom and pre-validated genomic pipelines. We deliver a suite of best-in-class tools for integrating whole genome, whole exome, targeted panels, somatic mutation and RNA-Seq workflows. Bina’s ensemble analysis also improves the accuracy of common open source tools to deliver greater detection sensitivity and specificity.
Bina employs big data technologies to enable querying and annotation of variants from millions down to a handful — in a matter of minutes. Users can custom configure filter sets with access to over 140 annotations for visualization and instantaneous interaction with results.
Bina isn’t just stitching together existing open source tools. According to Michael Snyder, Professor and Chair of the Department of Genetics at Stanford University, our highly tuned big data platform has enhanced the custom pipeline at Stanford's Center for Genomics and Personalized Medicine to run up to 7 times faster. In addition, we invest heavily to improve the accuracy of analytical genomic results.
Bina massively reduces the time of genomic analysis for Stanford’s Center for Genomics and Personalized Medicine.
We provide fit-for-purpose user interfaces that work for a diverse set of needs, making it easy for bench scientists to specify standard workflows, and for bioinformaticians to customize analyses.
Our team of engineers, computer scientists, data architects, bioinformaticians and genomic experts can function as an extension of your organization. Our team is continually improving the performance of our analytical software, where enhancements for greater accuracy are seamlessly transferred through regularly supported updates.
Bina’s high performance genomic data analysis operates on an optimized and tested big data platform, allowing your organization to scale up and grow with minimal changes to your infrastructure. We validate our pipelines and test our software so you can spend your time on genomic data intelligence, instead of fixing broken analytical pipelines. Plus, our flexible deployment options deliver reliability and scale on-premises, in the cloud, or a hybrid of both.
Bina is committed to accelerating genomic research, irrespective of the sequencing platform used. As part of Roche Sequencing, Bina is also expanding its holistic solutions. By working very closely with upstream and downstream sequencing technology innovators, Roche and Bina aim to build a seamless, end-to-end solution that realizes the promise of precision medicine.